Roche Still Perfect In Accutane Appeals With Defiant Tactic
Hoffmann-LaRoche Inc.'s defeat of a $25 million verdict over its Accutane drug extends its perfect record challenging judgments in the long-running consolidated litigation, marked by what attorneys say is the drugmaker's...To view the full article, register now.
Already a subscriber? Click here to view full article